These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8828609)

  • 21. Treatment variables and intellectual outcome in children with classic phenylketonuria. A single-center-based study.
    Legido A; Tonyes L; Carter D; Schoemaker A; Di George A; Grover WD
    Clin Pediatr (Phila); 1993 Jul; 32(7):417-25. PubMed ID: 8365077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perceptual-motor functioning in children with phenylketonuria.
    Koff E; Boyle P; Pueschel SM
    Am J Dis Child; 1977 Oct; 131(10):1084-7. PubMed ID: 910759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. School performance and intellectual outcome in adolescents with phenylketonuria.
    Weglage J; Fünders B; Wilken B; Schubert D; Ullrich K
    Acta Paediatr; 1993; 82(6-7):582-6. PubMed ID: 8338995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stability of blood phenylalanine levels and IQ in children with phenylketonuria.
    Anastasoaie V; Kurzius L; Forbes P; Waisbren S
    Mol Genet Metab; 2008; 95(1-2):17-20. PubMed ID: 18703366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect on intelligence of relaxing the low phenylalanine diet in phenylketonuria.
    Smith I; Beasley MG; Ades AE
    Arch Dis Child; 1991 Mar; 66(3):311-6. PubMed ID: 2025007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intellectual assessment of 111 four-year-old children with phenylketonuria.
    Dobson JC; Williamson ML; Azen C; Koch R
    Pediatrics; 1977 Dec; 60(6):822-7. PubMed ID: 600594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria.
    Weglage J; Ullrich K; Pietsch M; Fünders B; Güttler F; Harms E
    Pediatr Res; 1997 Sep; 42(3):378-84. PubMed ID: 9284280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Executive functioning in children and adolescents with phenylketonuria.
    VanZutphen K; Packman W; Sporri L; Needham M; Morgan C; Weisiger K; Packman S
    Clin Genet; 2007 Jul; 72(1):13-8. PubMed ID: 17594394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of dietary control in phenylketonuric patients and its relationship with general intelligence.
    Vilaseca MA; Lambruschini N; Gómez-López L; Gutiérrez A; Fusté E; Gassió R; Artuch R; Campistol J
    Nutr Hosp; 2010; 25(1):60-6. PubMed ID: 20204257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropsychological studies on adolescents with phenylketonuria returned to phenylalanine-restricted diets.
    Clarke JT; Gates RD; Hogan SE; Barrett M; MacDonald GW
    Am J Ment Retard; 1987 Nov; 92(3):255-62. PubMed ID: 3426836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intellectual development in 12-year-old children treated for phenylketonuria.
    Azen CG; Koch R; Friedman EG; Berlow S; Coldwell J; Krause W; Matalon R; McCabe E; O'Flynn M; Peterson R
    Am J Dis Child; 1991 Jan; 145(1):35-9. PubMed ID: 1985428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wechsler subscale IQ and subtest profile in early treated phenylketonuria.
    Griffiths PV; Demellweek C; Fay N; Robinson PH; Davidson DC
    Arch Dis Child; 2000 Mar; 82(3):209-15. PubMed ID: 10685922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of life and adherence to treatment in early-treated Brazilian phenylketonuria pediatric patients.
    Vieira E; Maia HS; Monteiro CB; Carvalho LM; Tonon T; Vanz AP; Schwartz IVD; Ribeiro MG
    Braz J Med Biol Res; 2017 Dec; 51(2):e6709. PubMed ID: 29267500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychiatric disorders in adult patients with early-treated phenylketonuria.
    Pietz J; Fätkenheuer B; Burgard P; Armbruster M; Esser G; Schmidt H
    Pediatrics; 1997 Mar; 99(3):345-50. PubMed ID: 9041285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Final intelligence in late treated patients with phenylketonuria.
    Trefz FK; Cipcic-Schmidt S; Koch R
    Eur J Pediatr; 2000 Oct; 159 Suppl 2():S145-8. PubMed ID: 11043161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Care of the adult with phenylketonuria.
    Koch R; Azen C; Friedman EG; Fishler K; Baumann-Frischling C; Lin T
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S90-2. PubMed ID: 8828619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of the phenylalanine hydroxylase gene on maternal phenylketonuria outcome.
    Güttler F; Azen C; Guldberg P; Romstad A; Hanley WB; Levy HL; Matalon R; Rouse BM; Trefz F; de la Cruz F; Koch R
    Pediatrics; 2003 Dec; 112(6 Pt 2):1530-3. PubMed ID: 14654659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of treatment in young adults with phenylketonuria detected by routine neonatal screening between 1964 and 1971.
    Beasley MG; Costello PM; Smith I
    Q J Med; 1994 Mar; 87(3):155-60. PubMed ID: 8208903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment and control of patients with phenylketonuria: results from the Collaborative Group of Spanish Follow-up Units].
    Campistol J; González MJ; Gutiérrez AP; Vilaseca MA;
    Med Clin (Barc); 2012 Mar; 138(5):185-91. PubMed ID: 21794880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy and safety of a phenylalanine-free amino acid-based enteral formula (AA-PKU2) in 1-8 year-old children with phenylketonuria: a prospective, open, self-controlled and multi-center study in China].
    Zhou XL; Zhao ZY; Jiang JH; Zou H; Gu XF; Gu Q; Shen M; Lu J
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jan; 16(1):11-5. PubMed ID: 24461170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.